S.Amdt. 3331

SA 3331. Mr. DURBIN submitted an amendment intended to be proposed by
him to the bill S. 524, to authorize the Attorney General to award
grants to address the national epidemics of prescription opioid abuse
and heroin use; which was ordered to lie on the table; as follows:

At the end of title VI, insert the following:

SEC. 602. PRIORITY CONSIDERATION.

(a) Definitions.--The definitions in section 601(a) shall
apply to this section.
(b) Priority Consideration.--In awarding Federal funds
under a program of the Department of Justice or the
Department of Health and Human Services to be used for
prescription drug monitoring programs of the States, the
Attorney General or the Secretary of Health and Human
Services, as the case may be, shall give priority
consideration to an application from a State that--
(1) requires a prescriber of a schedule II, III, or IV
controlled substance to, prior to the issuance of a
prescription for a schedule II, III, or IV controlled
substance, consult the prescription drug monitoring database
of the State;
(2) requires a dispenser of a schedule II, III, or IV
controlled substance to, for the dispensing of each
prescription of a schedule II, III, or IV controlled
substance, input data to the prescription drug monitoring
database of the State, within 24 hours of the dispensing,
which shall include--
(A) a patient identifier;
(B) the national drug code of the dispensed drug;
(C) the date of dispensing;
(D) the quantity of the drug dispensed;
(E) the Drug Enforcement Administration registration number
of the prescriber; and
(F) the Drug Enforcement Administration registration number
of the dispenser;
(3) authorizes access to a State board responsible for the
licensure, regulation, or discipline of practitioners,
pharmacists, or other person who is authorized to prescribe,
administer, or dispense controlled substances; and
(4) requires that, not fewer than 4 times a year, the State
agency that administers the prescription drug monitoring
program of the State prepare and provide to--
(A) the State board described in paragraph (3), an
informational report concerning the prescribing patterns of
prescribers within the State, which shall include data on
aggregate trends and individual outliers that indicate a
substantial likelihood that inappropriate prescribing may be
occurring; and
(B) each prescriber of a schedule II, III, or IV controlled
substance, an information report that shows how the
prescribing patterns of the prescriber compare to the
prescribing practices of the peers of the prescriber and
expected norms.
______